Nealon W H, Matin S
Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555-0544, USA.
Ann Surg. 2001 Jun;233(6):793-800. doi: 10.1097/00000658-200106000-00009.
To determine whether surgical intervention prevents recurrent acute exacerbations in chronic pancreatitis (CP).
The primary goal of surgical intervention in the treatment of CP has been relief of chronic unrelenting abdominal pain. A subset of patients with CP have intermittent acute exacerbations, often with increasing frequency and often unrelated to ongoing ethanol abuse. Little data exist regarding the effectiveness of surgery to prevent acute attacks.
From 1985 to 1999, all patients identified with a diagnosis of CP were recruited to participate in an ongoing program of serial clinic visits and functional and clinical evaluations. Patients were offered surgery using standard criteria. Data were gathered regarding ethanol abuse, pain, narcotic use, and recurrent acute exacerbations requiring hospital admission before and after surgery. Patients were broadly categorized as having severe unrelenting pain alone (group 1), severe pain with intermittent acute exacerbations (group 2), and intermittent acute exacerbations only (group 3).
Two hundred fifty-nine patients were recruited. One hundred eighty-five patients underwent 199 surgical procedures (124 modified Puestow procedure [LPJ], 29 distal pancreatectomies [DP], and 46 pancreatic head resections [PHR; 14 performed after failure of LPJ]). There were no deaths. The complication rate was 4% for LPJ, 15% for DP, and 27% for PHR. Ethanol abuse was causative in 238 patients (92%). Mean follow-up was 81 months. There were 104 patients in group 1 (86 who underwent surgery), 71 patients in group 2 (64 who underwent surgery), and 84 in group 3 (49 who underwent surgery). No patient without surgery had spontaneous resolution of symptoms. Postoperative pain relief (freedom from narcotic analgesics) was achieved in 153 of 185 patients (83%) overall: 106 of 124 (86%) for LPJ, 19 of 29 (67%) for DP, and 42 of 46 (91%) for PHR. The mean rate of acute exacerbations was 6.3 +/- 2.1 events per year before surgery in group 2 and 7.8 +/- 1.8 events per year in group 3. After surgery, no acute exacerbations occurred in 42 of 64 (66%) group 2 patients and in 40 of 49 (82%) group 3 patients. The mean number of episodes of acute exacerbation after surgery was 1.6 +/- 2.3 events in group 2 and 1.1 +/- 1.9 events in group 3. Only four patients in group 2 and one patient in group 3 had an equal or increased frequency of attacks after surgery. Preventing attacks was most effective with LPJ (58/64, 91%) and least effective for DP (6/18, 33%).
Surgical intervention prevents recurrent acute exacerbations. The overall frequency of events was reduced in nearly all patients. Therefore, surgical intervention is indicated in patients with CP whose disease is characterized by recurrent acute exacerbations.
确定手术干预能否预防慢性胰腺炎(CP)的复发性急性加重。
CP手术治疗的主要目标一直是缓解慢性持续性腹痛。一部分CP患者有间歇性急性加重,发作频率往往增加,且常与持续酗酒无关。关于手术预防急性发作有效性的数据很少。
1985年至1999年,所有确诊为CP的患者被招募参加一个正在进行的系列门诊、功能和临床评估项目。按照标准标准为患者提供手术。收集了手术前后患者酗酒、疼痛、使用麻醉剂以及需要住院治疗的复发性急性加重的数据。患者大致分为仅患有严重持续性疼痛(第1组)、伴有间歇性急性加重的严重疼痛(第2组)和仅间歇性急性加重(第3组)。
招募了259例患者。185例患者接受了199例手术(124例改良普外斯托手术[LPJ]、29例胰体尾切除术[DP]和46例胰头切除术[PHR;14例在LPJ失败后进行])。无死亡病例。LPJ的并发症发生率为4%,DP为15%,PHR为27%。238例患者(92%)病因是酗酒。平均随访81个月。第1组有104例患者(86例接受手术),第2组有71例患者(64例接受手术),第3组有84例患者(49例接受手术)。未手术的患者症状均未自行缓解。总体上,185例患者中有153例(83%)术后疼痛缓解(无需使用麻醉性镇痛药):LPJ的124例中有106例(86%),DP的29例中有19例(67%),PHR的46例中有42例(91%)。第2组术前急性加重的平均发生率为每年6.3±2.1次,第3组为每年7.8±1.8次。术后,第2组64例患者中有42例(66%)未发生急性加重,第3组49例患者中有40例(82%)未发生急性加重。第2组术后急性加重的平均发作次数为1.6±2.3次,第3组为1.1±1.9次。第2组仅4例患者、第3组仅1例患者术后发作频率相等或增加。预防发作以LPJ最有效(58/64,91%),DP最无效(6/18,33%)。
手术干预可预防复发性急性加重。几乎所有患者的事件总体频率均降低。因此,对于以复发性急性加重为特征的CP患者,建议进行手术干预。